# Efficacy Study of Radiotherapy Alone Versus CCRT With Temozolomide in Grade III Gliomas Without 1p/19q Codeletion

> **NCT01534845** · PHASE2 · UNKNOWN · sponsor: **Jong Hoon Kim** · enrollment: 90 (actual)

## Conditions studied

- Anaplastic Glioma of Brain
- Loss of Chromosomes 1p/19q

## Interventions

- **DRUG:** Temozolomide (Temodal)

## Key facts

- **NCT ID:** NCT01534845
- **Lead sponsor:** Jong Hoon Kim
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-03
- **Primary completion:** 2015-02
- **Final completion:** 2017-02
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2015-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01534845

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01534845, "Efficacy Study of Radiotherapy Alone Versus CCRT With Temozolomide in Grade III Gliomas Without 1p/19q Codeletion". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT01534845. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*